Zhenyi Su

3.4k citations
31 papers · 2.3k · 2 hit papers · h-index 16

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Cell death mechanisms and regulation
    • RNA modifications and cancer
    • Circular RNAs in diseases

Papers in

    • Signaling Pathways in Disease 10
    • Cell death mechanisms and regulation 6
    • RNA Interference and Gene Delivery 4
    • NF-κB Signaling Pathways 9

Zhenyi Su

30 papers receiving 2.3k citations

Zhenyi Su's Hit Papers

Understanding the complexity of p53 in a new era of tumor suppression 2024 · 238 citations
2380+3+7Years since publication250500750

Peers

Zhenyi Su
Comparison fields: 5 of 108
  • Cancer Research 642
  • Molecular Biology 1.3k
  • Oncology 356
  • Immunology 279
  • Epidemiology 361
Replace In‐Chul Park with:
In‐Chul Park South Korea
Zuozhang Yang China
Kenneth W. Yip Canada
Noushin Nabavi Canada
Yingchao Wang China
Kezuo Hou China
Shiming Tan China
Diana Gulei Romania
Zhenyi Su relative to In‐Chul Park South Korea In‐Chul Park's profile →
Citations per field
00.5×3.1×
In‐Chul Park · 1×
Citations per year

Countries citing papers authored by Zhenyi Su

Since Specialization
Citations

This map shows the geographic impact of Zhenyi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyi Su more than expected).

Fields of papers citing papers by Zhenyi Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyi Su. The network helps show where Zhenyi Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Zhenyi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhenyi Su Line = papers co-authored together Zhenyi Su links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Apoptosis, autophagy, necroptosis, and cancer metastasis
Hit paper breakdown →
2015818
2 2015304
3 2016283
4
Understanding the complexity of p53 in a new era of tumor suppression
Hit paper breakdown →
2024238
5 2019114
6 201785
7 202372
8 201657
9 201456
10 202342
11 201325
12 202425
13 201524
14 202122
15 201820
16 201518
17 201213
18 201113
19 202413
20 202512

About Zhenyi Su

Zhenyi Su is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Immunology, having authored 31 papers that have together received 2.3k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (10 papers), NF-κB Signaling Pathways (9 papers), Cell death mechanisms and regulation (6 papers), RNA Interference and Gene Delivery (4 papers), Cancer-related Molecular Pathways (4 papers), Ferroptosis and cancer prognosis (3 papers), Quantum Dots Synthesis And Properties (3 papers) and Chalcogenide Semiconductor Thin Films (3 papers). The work is most often cited by research in Cancer Research (642 citations), Molecular Biology (1.3k citations), Oncology (356 citations), Immunology (279 citations) and Epidemiology (361 citations). Zhenyi Su has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Zuozhang Yang, Qiang Yu, Yongqing Xu, Yongbin Chen, Wei Gu, Yanqing Liu, Yongbin Chen, Omid Tavana, Judy Park DeWitt and Lin Xie. Their work appears in journals such as Cell Death and Differentiation, Biochemical and Biophysical Research Communications, Cell Death and Disease, Molecular Cancer and Biochimie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact